Search research articles
Contact Us
Filters
Showing results (21-30 of 177) with videos related to
Page
of 18
Sort By:
European Journal of Pharmacology
|
July 27, 1990
Baseline and apomorphine-induced extracellular levels of nigral substance P are increased in an animal model of Parkinson's disease
D Orosz, J P Bennett
Annals of the Royal College of Surgeons of England
|
November 1, 1994
Moles and melanoma: a history
J P Bennett, P Hall
British Journal of Plastic Surgery
|
October 1, 1981
The preservation of lachrymal drainage following excision of basal cell carcinoma of the lower eyelid
J P Bennett, A Werb
Experimental Neurology
|
March 1, 1992
Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the "hemiparkinsonian" rat
D Orosz, J P Bennett
Molecular Pharmacology
|
May 1, 1976
Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors
J P Bennett, S H Snyder
Environmental Pollution (Barking, Essex : 1987)
|
January 1, 1995
BIOLEFF: three databases on air pollution effects on vegetation
J P Bennett, M J Buchen
Neurology
|
August 1, 1993
Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease
L A Schuh, J P Bennett
Brain Research. Developmental Brain Research
|
July 20, 1996
Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors
A B Jung, J P Bennett
Annals of Neurology
|
April 1, 1986
Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease
J P Bennett, G F Wooten
Trends in Neurosciences
|
December 1, 1992
Are neurotransmitter carriers cell-specific markers?
J P Bennett, M B Lowrie
Page
of 18
Search research articles
Search
Showing results (21-30 of 177) with videos related to
Sort By:
Page
of 18
European Journal of Pharmacology
|
July 27, 1990
Baseline and apomorphine-induced extracellular levels of nigral substance P are increased in an animal model of Parkinson's disease
D Orosz, J P Bennett
Annals of the Royal College of Surgeons of England
|
November 1, 1994
Moles and melanoma: a history
J P Bennett, P Hall
British Journal of Plastic Surgery
|
October 1, 1981
The preservation of lachrymal drainage following excision of basal cell carcinoma of the lower eyelid
J P Bennett, A Werb
Experimental Neurology
|
March 1, 1992
Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the "hemiparkinsonian" rat
D Orosz, J P Bennett
Molecular Pharmacology
|
May 1, 1976
Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors
J P Bennett, S H Snyder
Environmental Pollution (Barking, Essex : 1987)
|
January 1, 1995
BIOLEFF: three databases on air pollution effects on vegetation
J P Bennett, M J Buchen
Neurology
|
August 1, 1993
Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease
L A Schuh, J P Bennett
Brain Research. Developmental Brain Research
|
July 20, 1996
Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors
A B Jung, J P Bennett
Annals of Neurology
|
April 1, 1986
Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease
J P Bennett, G F Wooten
Trends in Neurosciences
|
December 1, 1992
Are neurotransmitter carriers cell-specific markers?
J P Bennett, M B Lowrie
Page
of 18